Abstract
Cetuximab given concurrently with radiotherapy has recently been reported to result in a survival benefit for patients with locally advanced squamous-cell carcinoma of the head and neck, without increasing the toxic effects of radiotherapy.1 We report two cases of severe radiation dermatitis during the course of radiotherapy for squamous-cell carcinoma of the head and neck with concomitant use of cetuximab; these two cases of dermatitis occurred among five patients treated according to this protocol at our institution.

This publication has 2 references indexed in Scilit: